MEF2C and familial dilated cardiomyopathy: Overexpression of miR-133a has been shown to prevent hypertrophic changes in DCM by downregulating the serum and glucocorticoid-regulated kinase 1 (SGK1), IGFR1 and myocyte-specific enhancer factor 2C (MEF2C) [26].